{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:06:38Z","timestamp":1792263998184,"version":"4.4.0"},"reference-count":52,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007281","name":"National Drug and Alcohol Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and aims<\/jats:title><jats:p>Mortality rates among people who use heroin are estimated to be 15 times that of the general population. The study aimed to determine (1) the case characteristics and circumstances of death of heroin\u2010related toxicity deaths in Australia, 2020\u20132022; (2) their toxicological profile and major autopsy findings; (3) the proportion of cases in which blood 6\u2010acetyl morphine (6AM) was detected, as a proxy measure of survival times; and (4) compare 6AM positive and negative cases on toxicology, circumstances of death and acute clinical presentation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective study of heroin toxicity deaths in Australia, 2020\u20132022, retrieved from the National Coronial Information System.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>This study was conducted Australia\u2010wide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Cases<\/jats:title><jats:p>There were 610 cases of fatal heroin\u2010related drug toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Information was collected on characteristics, manner of death, toxicology and autopsy results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>The mean age was 42.6\u2009years (range 18\u201373\u2009years), 80.5% were male and 7.5% were enrolled in a drug treatment programme. The circumstances of death were as follows: unintentional drug toxicity (86.2%), combined unintentional drug toxicity\/disease (11.3%) and intentional drug toxicity (2.5%). The median free morphine concentration was 0.17\u2009mg\/L (range 0.00\u20134.20\u2009mg\/L). Psychoactive drugs other than heroin were present in 95.2% (Confidence Interval 93.1%\u201396.8%), most commonly hypnosedatives (62.3%, 58.2%\u201366.4%) and psychostimulants (44.8%, 40.7%\u201349.1%). Major autopsy findings of clinical significance included acute bronchopneumonia (14.8%, 11.3%\u201318.8%), emphysema (16.9%, 13.2%\u201321.1%), cardiomegaly (30.1%, 12.7%\u201328.2%), coronary artery disease (27.4%, 23.0%\u201332.3%), coronary replacement fibrosis (13.4%, 10.1%\u201317.3%), hepatic cirrhosis (8.8%, 6.6%\u201312.2%) and renal fibrosis (10.3%, 7.3%\u201314.0%). In 47.0% (42.3%\u201351.2%), 6AM was present in blood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The \u2018typical\u2019 heroin overdose case in Australia from 2020 to 2022 was a male who injected heroin, aged in the 40s, not enrolled in a treatment programme and had used multiple drugs. In over half of cases, there had been a sufficient survival time for 6\u2010acetyl morphine to have been metabolised, which may indicate times in excess of 20\u201330\u2009min.<\/jats:p><\/jats:sec>","DOI":"10.1111\/add.16377","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T09:48:40Z","timestamp":1699004920000},"page":"559-569","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A descriptive coronial study of heroin toxicity deaths in Australia, 2020\u20132022: Characteristics, toxicology and survival times"],"prefix":"10.1111","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-7055","authenticated-orcid":false,"given":"Shane","family":"Darke","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5863-635X","authenticated-orcid":false,"given":"Johan","family":"Duflou","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales  Sydney Australia"},{"name":"Sydney Medical School University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-2026","authenticated-orcid":false,"given":"Amy","family":"Peacock","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-8130","authenticated-orcid":false,"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5946-2144","authenticated-orcid":false,"given":"Julia","family":"Lappin","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales  Sydney Australia"},{"name":"School of Psychiatry University of New South Wales  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32229-9"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.03.010"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.4170"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0976"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12337"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.07.030"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103245"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674231159298"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13779"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.035"},{"key":"e_1_2_9_12_1","volume-title":"Disposition of toxic drugs and chemicals in man (12th edition)","author":"Baselt RC","year":"2020"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15014"},{"key":"e_1_2_9_14_1","volume-title":"Karch's pathology of drug abuse (5th edition)","author":"Karch SB","year":"2015"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13429"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.02.024"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.09.001"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02025.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03140.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.06.004"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00376.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.07.014"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01495.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00147-7"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00330.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS12902J"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcfm.2004.04.008"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/19.3.163"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg029"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00128-9"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(98)00003-6"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS10410J"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6474188"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2018.1529319"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.18356\/9789210019545"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14713"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16055"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13252"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13468"},{"key":"e_1_2_9_41_1","volume-title":"NCIS coding manual (version 5)","author":"National Coronial Information System","year":"2020"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)64946-5"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)64945-3"},{"key":"e_1_2_9_44_1","volume-title":"SPSS for Windows, 27.0","author":"IBM Inc","year":"2021"},{"key":"e_1_2_9_45_1","first-page":"1","article-title":"The life cycle of the narcotic addict and of addiction","volume":"16","author":"Winick C","year":"1964","journal-title":"Bull Narcotics"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15911"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826088309027349"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563657808988229"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15736"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.05.001"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13645"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14486"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2492"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.16377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T01:57:22Z","timestamp":1707098242000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.16377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1111\/add.16377"],"URL":"https:\/\/doi.org\/10.1111\/add.16377","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"2023-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}